What causes hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Causes Hypercalcemia

The two most common causes of hypercalcemia are primary hyperparathyroidism (accounting for approximately 90% of outpatient cases) and malignancy (responsible for most inpatient cases and 10-25% of patients with cancer). 1, 2, 3

Primary Causes by Clinical Setting

Outpatient Hypercalcemia

  • Primary hyperparathyroidism is the leading cause in ambulatory patients, characterized by elevated or inappropriately normal PTH levels despite hypercalcemia 1, 2
  • This condition results from autonomous parathyroid hormone secretion, leading to increased bone resorption and calcium absorption 3

Inpatient Hypercalcemia

  • Malignancy-associated hypercalcemia dominates in hospitalized patients, with particularly poor prognosis (median survival approximately 1 month) 1
  • Two distinct mechanisms occur in malignancy:
    • Humoral hypercalcemia: PTH-related protein (PTHrP) secretion by tumors (squamous cell lung cancer, head/neck cancers, renal cell carcinoma, ovarian cancer) stimulates systemic bone resorption even without skeletal metastases 2, 4
    • Local osteolytic hypercalcemia: Direct tumor invasion of bone (breast cancer, multiple myeloma) releases local factors that activate osteoclasts 2, 4

Additional Important Causes

Vitamin D-Related Disorders

  • Granulomatous diseases (particularly sarcoidosis) cause hypercalcemia through increased production of 1,25-dihydroxyvitamin D by activated macrophages 2, 3
  • Vitamin D intoxication from excessive supplementation leads to increased intestinal calcium absorption 5, 2
  • Lymphomas can produce vitamin D metabolites, causing hypercalcemia 3, 6

Medication-Induced Hypercalcemia

  • Thiazide diuretics reduce renal calcium excretion 3, 7
  • Lithium alters parathyroid gland calcium sensing 7
  • Calcium and vitamin D supplements, particularly in patients with chronic kidney disease and low-turnover bone disease, frequently cause hypercalcemia 5
  • Vitamin D toxicity typically occurs at 25(OH)D levels >150 ng/mL (>375 nmol/L) 5

Chronic Kidney Disease

  • Patients with CKD receiving calcium-based phosphate binders and/or active vitamin D sterols frequently develop hypercalcemia 5
  • Spontaneous hypercalcemia also occurs in CKD patients, particularly those with low-turnover bone disease 5
  • Tertiary hyperparathyroidism in advanced CKD can cause hypercalcemia 7

Endocrine Disorders

  • Thyrotoxicosis increases bone turnover and calcium release 7
  • Williams syndrome causes idiopathic infantile hypercalcemia 2

Other Causes

  • Familial hypocalciuric hypercalcemia (FHH) is a benign genetic condition that must be distinguished from primary hyperparathyroidism before considering surgery 7, 8
  • Immobilization reduces mechanical stress on bone, increasing resorption 3, 7
  • Milk-alkali syndrome from excessive calcium and alkali intake 7

Pathophysiologic Mechanism

The final common pathway involves excessive bone resorption by osteoclasts, releasing calcium into the bloodstream 9, 4. This triggers:

  • Polyuria and gastrointestinal disturbances leading to progressive dehydration 9, 4
  • Decreased glomerular filtration rate 9, 4
  • Increased renal calcium reabsorption, creating a vicious cycle of worsening hypercalcemia 9, 4

Critical Diagnostic Distinction

Measure intact PTH to differentiate causes: 1, 3

  • Elevated or inappropriately normal PTH: Primary hyperparathyroidism 1, 2
  • Suppressed PTH (<20 pg/mL): Malignancy, vitamin D disorders, medications, or other non-PTH-mediated causes 3, 8

References

Guideline

Hypercalcemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hypercalcemia Causes and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypercalcemia: A Review.

JAMA, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of hypercalcemia.

Endocrinology and metabolism clinics of North America, 1989

Research

Investigation of hypercalcemia.

Clinical biochemistry, 2012

Research

A practical approach to hypercalcemia.

American family physician, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.